BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31087464)

  • 1. Review of autoimmune blistering diseases: the Pemphigoid diseases.
    Daniel BS; Murrell DF
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
    Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
    An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
    Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
    J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantigens of subepidermal bullous autoimmune dermatoses].
    Georgi M; Jainta S; Bröcker EB; Zillikens D
    Hautarzt; 2001 Dec; 52(12):1079-89. PubMed ID: 11910857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital.
    Jain S; Basavaraj V; Vimala MG
    Turk Patoloji Derg; 2016; 32(2):91-8. PubMed ID: 27136107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory.
    Schmidt E; Zillikens D
    Adv Dermatol; 2000; 16():113-57; discussion 158. PubMed ID: 11094626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review.
    Edwards G; Diercks GFH; Seelen MAJ; Horvath B; van Doorn MBA; Damman J
    Front Immunol; 2019; 10():1477. PubMed ID: 31293600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
    Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
    J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and bullous diseases.
    Stoj V; Lu J
    Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linear IgA bullous dermatosis in children with autoantibodies against 180 kDa pemphigoid antigen].
    Bérard F; Kanitakis J; Di Maio M; Ghohestani R; Hermier C; David L; Claudy A; Faure M
    Arch Pediatr; 1996 Apr; 3(4):345-7. PubMed ID: 8762956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen.
    Kanitakis J; Mauduit G; Cozzani E; Badinand P; Faure M; Claudy A
    Pediatr Dermatol; 1994 Jun; 11(2):139-44. PubMed ID: 8041654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bullous autoimmune dermatoses of the mucous membranes].
    Didona D; Hinterseher J; Eming R
    Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blistering diseases.
    Scott JE; Ahmed AR
    Med Clin North Am; 1998 Nov; 82(6):1239-83. PubMed ID: 9889748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.